期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 135, 期 3, 页码 649-656出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjp.0704502
关键词
oxytocin; vasopressin; hypothalamus; 3,4-methylenedioxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine, 3,4-dihydroxyamphetamine; 3,4-dihydroxymethamphetamine; 4-hydroxy-3-methoxyamphetamine; 3,4-methylenedioxyamphetine
1 Methylenedioxymethamphetamine (MDMA, 'ecstasy'), widely used as a recreational drug, can produce hyponatraemia. The possibility that this could result from stimulation of vasopressin by MDMA or one of its metabolites has been investigated in vitro. 2 Release of both oxytocin and vasopressin from isolated hypothalami obtained from male Wistar rats was determined under basal conditions and following potassium (40 mM) stimulation, The results were compared with those obtained for basal and stimulated release in the presence of MDMA or metabolites in the dose range 1 muM to 100 muM (n = 5 - 8) using Student's t-test with Dunnett's correction for multiple comparisons. 3 All compounds tested affected neurohypophysial hormone release, HMMA (4-hydroxy-3-methoxymethamphetamine) and DHA (3,4-dihydroxyamphetamine) being more active than MDMA, and DHMA (3,4-dihydroxymethamphetamine) being the least active. The effect on vasopressin release was greater than that on oxytocin. In the presence of HMMA the ratio test:control for basal release increased for vasopressin from 1.1 +/- 0.16 to 2.7 +/- 0.44 (s.e.m., P < 0.05) at 10 nM and for oxytocin from 1.0 +/- 0.05 to 1.6 +/- 0.12 in the same hypothalami. For MDMA the ratio increased to 1.5 +/- 0.27 for vasopressin and to 1.28 +/- 0.04 for oxytocin for 10 nM. 4 MDMA and its metabolites can stimulate both oxytocin and vasopressin release in vitro, the response being dose dependent for each drug with HMMA being the most potent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据